/

RXST

RxSight, Inc.Pre-market

4.53−0.13 −2.79%USD

NasdaqGM · as of Oct 13, 16:00 ET · 15m delay

Open

4.68

Prev close

4.66

Day range

4.454.77

52-week range

4.4513.22

Volume

694.76K0.81×

Mkt cap

188.42M

P/E ttm

—

Fwd P/E

-6.63

EPS ttm

-1.14

Div yield

0.00%

Earnings

Aug 5, 2026

From 52w high

−65.73%

Price Chart

Yahoo Finance · delayed

RXSTOct 13, 2026O 4.68H 4.77L 4.45C 4.53−0.13 (−2.79%)Vol 694.90K

SMA 505.83
SMA 2006.71

1Y change −40.12% since Oct 13, 2025 close539 bars loadedTimes in America/New_YorkDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

RXST RxSight, Inc. · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −2.58%
1 month: −24.75%
3 months: −7.93%
6 months: −37.69%
Year to date: −56.53%
1 year: −40.12%

Valuation & ownership

Market cap: 188.42M
Enterprise value: −9.80M
P/E (ttm): —
Forward P/E: -6.63
PEG ratio: —
Price / book: 0.72
Price / sales (ttm): 1.48
EV / EBITDA: 0.19
EPS (ttm): -1.14
EPS (forward): -0.6834
Beta (5y monthly): 1.14
Dividend yield: 0.00%
Payout ratio: 0.00%
Shares outstanding: 41.59M
Float: 33.71M
Short % of float: 10.37%
Short ratio (days): 4.88
Held by insiders: 6.57%
Held by institutions: 104.45%
Avg volume (3m): 862.60K
50-day average: 5.86
200-day average: 6.74
52-week change: −40.12%
S&P 500 52-week: +17.03%

Technicals (daily)

RSI (14): 31.8
vs 50-day SMA: −22.25%
vs 200-day SMA: −32.47%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▲ above
ATR (14) % of price: 6.13%
Realised vol (20d, ann.): 34.9%
From 52-week high: −65.73%
From 52-week low: +1.91%

ANR

Analyst Consensus

8 analysts

Consensus

Hold

3.10 on a 1 (strong buy) – 5 (sell) scale

Mean target

7.57

+67.08% implied

Low 5.50Median 6.65High 11.00

Recommendation trend

Now1 / 7 / 2
1m ago1 / 7 / 2

DES

About RxSight, Inc.

Yahoo Finance profile

RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Sector: Healthcare
Industry: Medical Devices
Employees: 461
Headquarters: Aliso Viejo, CA, United States
Website: rxsight.com
Officers: Dr. Ilya Goldshleger Ph.D. Chief Operating Officer
Mr. Eric J. Weinberg Chief Business Development Officer
Dr. Ronald M. Kurtz M.D. Chief Medical Officer

SEAS

Seasonality · RXST

2021–2026 · monthly returns

Strongest month May +15.88%Weakest month Jul −10.49%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	-16.6	-13.9	-17.6	14.8	-24.6	-9.6	24.7	22.0	-33.2	-7.6			−56.5%
2025	-1.5	-16.3	-11.0	-41.7	3.9	-15.0	-40.2	16.2	-0.6	-2.2	29.9	-8.8	−69.7%
2024	12.9	19.9	-5.5	1.1	12.2	2.9	-23.9	23.2	-12.3	2.5	-7.5	-26.7	−14.7%
2023	10.5	-2.0	21.6	7.3	36.1	18.2	15.9	-13.1	-3.9	-20.6	36.2	33.7	+218.2%
2022	-8.5	30.4	-7.7	-0.9	11.3	3.1	6.3	-16.4	-4.1	3.7	2.7	-0.8	+12.6%
2021								-3.9	-17.6	-5.4	-9.4	3.7	−29.7%

INSD

Insider Activity · RXST

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

419.4K shares

Sells, 6 months

16.9K shares

Net shares

+402.5K

Net change in insider shares

+17.30%

Date	Insider	Transaction	Shares	Value
Sep 14, 2026	Weinberg EricOfficer	Conversion of Exercise of derivative security at price 4.34 per share.	35.2K	$152.63K
Sep 1, 2026	Weinberg EricOfficer	Sale at price 6.96 per share.	2K	$14.21K
Sep 1, 2026	Kurtz Ronald MOfficer	Sale at price 6.96 per share.	5.1K	$35.50K
Sep 1, 2026	Goldshleger IlyaChief Operating Officer	Sale at price 6.96 per share.	2K	$14.21K
Sep 1, 2026	Wilterding MarkChief Financial Officer	Sale at price 6.96 per share.	7.8K	$54.04K
Aug 30, 2026	Weinberg EricOfficer	—	5.4K	—
Aug 30, 2026	Kurtz Ronald MOfficer	—	13.4K	—
Aug 30, 2026	Goldshleger IlyaChief Operating Officer	—	5.4K	—
Aug 30, 2026	Wilterding MarkChief Financial Officer	—	20.4K	—
Jun 16, 2026	Fountain Tamara R.Director	Stock Award(Grant) at price 0.00 per share.	37K	—
Jun 16, 2026	Palmisano Robert JDirector	Stock Award(Grant) at price 0.00 per share.	37K	—
Jun 16, 2026	Cohen Raymond WDirector	Stock Award(Grant) at price 0.00 per share.	30.9K	—
Jun 16, 2026	Andrews JulieDirector	Stock Award(Grant) at price 0.00 per share.	37K	—
Jun 16, 2026	Tammenoms Bakker JulietDirector	Stock Award(Grant) at price 0.00 per share.	37K	—
Jun 16, 2026	Link William JDirector	Stock Award(Grant) at price 0.00 per share.	37K	—
Jun 16, 2026	Maniar Shweta SinghDirector	Stock Award(Grant) at price 0.00 per share.	37K	—
Jun 16, 2026	Corley Jesse AndersonDirector	Stock Award(Grant) at price 0.00 per share.	37K	—
Jun 16, 2026	Warner Robert KeithDirector	Stock Award(Grant) at price 0.00 per share.	37K	—
Apr 16, 2026	Goldshleger IlyaChief Operating Officer	Conversion of Exercise of derivative security at price 4.13 per share.	12.5K	$51.58K
Feb 26, 2026	Gaines ScottOfficer	—	6.3K	—

13F

Investors Holding RXST

latest 13F filings of 29 followed managers

Investors holding RXST
Investor	Value	Of portfolio	Shares	Change	Quarter
Renaissance Technologies	$678.1K	0.00%	140.69K	+133%	Q2 2026

From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors

RXST

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

RXST

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About RxSight, Inc.

Seasonality · RXST

Insider Activity · RXST

Congress Trades · RXST

Investors Holding RXST

Investors Holding RXST

Congress Trades · RXST

Insider Activity · RXST

Seasonality · RXST

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About RxSight, Inc.

Financial Snapshot

Earnings & Dividends

News